Target Audience
The target learning audience is a national audience of dermatologists, dermatology physician assistants, nurse practitioners, and other clinicians who treat patients with moderate-to-severe psoriasis.
Learning Objectives
At the conclusion of this activity, participants should be better able to:
- Describe the most common adverse events associated with biologic treatments for psoriasis
- Select biologic treatments based on patient characteristics and comorbid conditions
- Apply the results of clinical trials, expert recommendations, and consensus guidelines to develop treatment plans
Faculty
Steven Feldman, MD, PhD
Department of Dermatology
Wake Forest School of Medicine
Winston-Salem, North Carolina
Accreditation
The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council
for Continuing Medical Education to provide continuing medical education for physicians.
The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a
maximum of
1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in
the activity.
Disclosure Statement
It is the policy of the Annenberg Center for Health Sciences to ensure fair balance,
independence, objectivity, and scientific rigor in all programming. All faculty and planners
participating in sponsored programs are expected to identify and reference off-label product use
and disclose any relationship with those supporting the activity or any others with products or
services available within the scope of the topic being discussed in the educational
presentation.
The Annenberg Center for Health Sciences assesses conflict of interest with its instructors,
planners, managers, and other individuals who are in a position to control the content of CE/CME
activities. All relevant conflicts of interest that are identified are thoroughly vetted by the
Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity,
and patient care recommendations. The Annenberg Center is committed to providing its learners
with high-quality CE/CME activities and related materials that promote improvements or quality
in healthcare and not a specific proprietary business interest of a commercial interest.
In accordance with the Accreditation Council for Continuing Medical Education Standards, parallel
documents from other accrediting bodies, and Annenberg Center for Health Sciences policy, the
following disclosures have been made:
Steven Feldman, MD, PhD
- Research Support: AbbVie, Celgene, Galderma Laboratories, LP, Janssen, Lilly, Novartis Pharmaceuticals Corporation, Pfizer Inc, Regeneron, Sanofi, Taro
- Consultant: AbbVie, Advance Medical, Alvotech, Caremark, Celgene, Galderma Laboratories, LP, Gerson Lehrman Group, Guidepoint Global, Janssen, Kikaku, Leo Pharma Inc, Lilly, Merck & Co, Inc, Mylan, Novartis Pharmaceuticals Corporation, Pfizer Inc, Regeneron, Sanofi, Sienna, Sun Pharma, Suncare Research, Ortho Dermatologics, Xenoport
- Speakers Bureau: AbbVie, Celgene, Janssen, Leo Pharma Inc, Lilly, Novartis Pharmaceuticals Corporation, Ortho Dermatologics, Pfizer Inc, Regeneron, Sanofi, Sun Pharma, Taro
- Significant Shareholder: Causa Technologies, Medical Quality Enhancement Corporation
- Royalties: Informa, UpToDate, Xlibris
- Other: Founder and Chief Technology Officer of Causa Technologies
The faculty for this activity has disclosed that there will be
discussion about the use of products for non-FDA approved applications.
Additional Content Planners
Chris Fisher (Medical Writer): No significant relationships to disclose.
Coy Flowers, MD (Peer Reviewer): No significant relationships to disclose.
Annenberg Center for Health Sciences
Staff at the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial
relationships to disclose.
The ideas and opinions presented in this educational activity are those of the faculty and do not
necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational
activities, we encourage practitioners to use their own judgment in treating and addressing the
needs of each individual patient, taking into account that patient's unique clinical situation.
The Annenberg Center disclaims all liability and cannot be held responsible for any problems
that may arise from participating in this activity or following treatment recommendations
presented.
This activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.
This activity is an online enduring material. Successful completion is achieved by reading and/or
viewing the material, reflecting on its implications in your practice, and completing the
assessment component.
The estimated time to complete the activity is
1 hour.
This activity was originally released on
September 30, 2019 and is eligible for credit through
September 30, 2020.
Our Policy on Privacy
Annenberg Center for Health Sciences respects your privacy. We don’t share information you
give us, or have the need to share this information in the normal course of providing the
services and information you may request. If there should be a need or request to share this
information, we will do so only with your explicit permission. See Privacy Statement and other
information at http://www.annenberg.net/privacy-policy/
Contact Information
Annenberg Center for Health Sciences
39000 Bob Hope Drive
Dinah Shore Building
Rancho Mirage, CA 92270
ce@annenberg.net
Phone: 760-773-4500
Fax: 760-773-4513
8 am – 5 pm, Pacific Time, Monday – Friday